Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Standard

Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study. / Huber, Roman; von Ditfurth, Amelie; Amann, Frank et al.
in: Journal of Clinical Gastroenterology, Jahrgang 41, Nr. 9, 01.10.2007, S. 834-838.

Publikation: Beiträge in ZeitschriftenZeitschriftenaufsätzeForschungbegutachtet

Harvard

Huber, R, von Ditfurth, A, Amann, F, Güthlin, C, Rostock, M, Trittler, R, Kümmerer, K & Merfort, I 2007, 'Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study', Journal of Clinical Gastroenterology, Jg. 41, Nr. 9, S. 834-838. https://doi.org/10.1097/MCG.0b013e31804b2173

APA

Huber, R., von Ditfurth, A., Amann, F., Güthlin, C., Rostock, M., Trittler, R., Kümmerer, K., & Merfort, I. (2007). Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study. Journal of Clinical Gastroenterology, 41(9), 834-838. https://doi.org/10.1097/MCG.0b013e31804b2173

Vancouver

Huber R, von Ditfurth A, Amann F, Güthlin C, Rostock M, Trittler R et al. Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study. Journal of Clinical Gastroenterology. 2007 Okt 1;41(9):834-838. doi: 10.1097/MCG.0b013e31804b2173

Bibtex

@article{b2e0de7fe4ee4b6790ab5451cd9ffb14,
title = "Tormentil for active ulcerative colitis: An Open-Label, Dose-Escalating Study",
abstract = "BACKGROUND: Tormentil extracts (TE) have antioxidative properties and are used as a complementary therapy for chronic inflammatory bowel disease. In individual patients with ulcerative colitis (UC) positive effects have been observed. GOALS: To assess the safety, pharmacology, and clinical effects of different doses of TE in patients with active UC. STUDY: Sixteen patients with active UC [clinical activity index (CAI) ≥5] received TE in escalating doses of 1200, 1800, 2400 and 3000 mg/d for 3 weeks each. Each treatment phase was followed by a 4-week washout phase. The outcome parameters were side effects, CAI, C-reactive protein, and tannin levels in patient sera. RESULTS: Mild upper abdominal discomfort was experienced by 6 patients (38%), but did not require discontinuation of the medication. During therapy with 2400 mg TE per day, median CAI and C-reactive protein improved from 8 (6 to 10.75) and 8 (3 to 17.75) mg/L at baseline to 4.5 (1.75 to 6) and 3 (3 to 6) mg/L, respectively. During therapy, the CAI decreased in all patients, whereas it increased during the washout phase. Neither undegraded nor metabolized tannins could be detected by liquid-mass spectrometry (LC-MS) in patient sera. CONCLUSIONS: TE appeared safe up to 3000 mg/d. Tannins from TE are not systemically absorbed. The efficacy in patients with UC should be further evaluated.",
keywords = "Chemistry, CAI, Cohort study, Tannins, Ulcerative colitis",
author = "Roman Huber and {von Ditfurth}, Amelie and Frank Amann and Corina G{\"u}thlin and Matthias Rostock and Rainer Trittler and Klaus K{\"u}mmerer and Irmgard Merfort",
year = "2007",
month = oct,
day = "1",
doi = "10.1097/MCG.0b013e31804b2173",
language = "English",
volume = "41",
pages = "834--838",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

RIS

TY - JOUR

T1 - Tormentil for active ulcerative colitis

T2 - An Open-Label, Dose-Escalating Study

AU - Huber, Roman

AU - von Ditfurth, Amelie

AU - Amann, Frank

AU - Güthlin, Corina

AU - Rostock, Matthias

AU - Trittler, Rainer

AU - Kümmerer, Klaus

AU - Merfort, Irmgard

PY - 2007/10/1

Y1 - 2007/10/1

N2 - BACKGROUND: Tormentil extracts (TE) have antioxidative properties and are used as a complementary therapy for chronic inflammatory bowel disease. In individual patients with ulcerative colitis (UC) positive effects have been observed. GOALS: To assess the safety, pharmacology, and clinical effects of different doses of TE in patients with active UC. STUDY: Sixteen patients with active UC [clinical activity index (CAI) ≥5] received TE in escalating doses of 1200, 1800, 2400 and 3000 mg/d for 3 weeks each. Each treatment phase was followed by a 4-week washout phase. The outcome parameters were side effects, CAI, C-reactive protein, and tannin levels in patient sera. RESULTS: Mild upper abdominal discomfort was experienced by 6 patients (38%), but did not require discontinuation of the medication. During therapy with 2400 mg TE per day, median CAI and C-reactive protein improved from 8 (6 to 10.75) and 8 (3 to 17.75) mg/L at baseline to 4.5 (1.75 to 6) and 3 (3 to 6) mg/L, respectively. During therapy, the CAI decreased in all patients, whereas it increased during the washout phase. Neither undegraded nor metabolized tannins could be detected by liquid-mass spectrometry (LC-MS) in patient sera. CONCLUSIONS: TE appeared safe up to 3000 mg/d. Tannins from TE are not systemically absorbed. The efficacy in patients with UC should be further evaluated.

AB - BACKGROUND: Tormentil extracts (TE) have antioxidative properties and are used as a complementary therapy for chronic inflammatory bowel disease. In individual patients with ulcerative colitis (UC) positive effects have been observed. GOALS: To assess the safety, pharmacology, and clinical effects of different doses of TE in patients with active UC. STUDY: Sixteen patients with active UC [clinical activity index (CAI) ≥5] received TE in escalating doses of 1200, 1800, 2400 and 3000 mg/d for 3 weeks each. Each treatment phase was followed by a 4-week washout phase. The outcome parameters were side effects, CAI, C-reactive protein, and tannin levels in patient sera. RESULTS: Mild upper abdominal discomfort was experienced by 6 patients (38%), but did not require discontinuation of the medication. During therapy with 2400 mg TE per day, median CAI and C-reactive protein improved from 8 (6 to 10.75) and 8 (3 to 17.75) mg/L at baseline to 4.5 (1.75 to 6) and 3 (3 to 6) mg/L, respectively. During therapy, the CAI decreased in all patients, whereas it increased during the washout phase. Neither undegraded nor metabolized tannins could be detected by liquid-mass spectrometry (LC-MS) in patient sera. CONCLUSIONS: TE appeared safe up to 3000 mg/d. Tannins from TE are not systemically absorbed. The efficacy in patients with UC should be further evaluated.

KW - Chemistry

KW - CAI

KW - Cohort study

KW - Tannins

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=34548851444&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/6e11987b-b0ce-3fa5-95df-cf08a6854a8b/

U2 - 10.1097/MCG.0b013e31804b2173

DO - 10.1097/MCG.0b013e31804b2173

M3 - Journal articles

VL - 41

SP - 834

EP - 838

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 9

ER -

DOI

Zuletzt angesehen

Forschende

  1. Carlos Vittar

Publikationen

  1. Effectiveness of an Internet-Based Self-Help Intervention versus Public Mental Health Advice to Reduce Worry during the COVID-19 Pandemic
  2. Anaerobic Inhibition and Biodegradation of Antibiotics in ISO Test Schemes
  3. Predicting satisfaction with democracy in Germany using local economic conditions, social capital, and individual characteristics
  4. The New Media
  5. Didactics of Mathematics in Higher Education as a Scientific Discipline - Conference Proceedings
  6. To Own or to Use
  7. Reflecting on the Roles and Skill Sets of Designers and Design Researchers
  8. Walter Benjamin. Der Autor als Produzent
  9. Touching Things
  10. Tasks and Evaluation of Human Resource Departments
  11. Information Communication Technology as Creativity Support Tools?
  12. The role of expert feedback in the development of pre-service teachers’ professional vision of classroom management in an online blended learning environment
  13. Potential of mobility services
  14. The difficulty of behavior as a (regulated) natural monopolist
  15. Institutional entrepreneurship for responsible digital innovation
  16. The Development of Civil Societies
  17. The art of crowdfunding arts and innovation
  18. Der Zeitpfeil im Digitalen
  19. Toward industrial silicone 3D printing of soft robots
  20. Sustainable chemistry and food systems lessons-the same procedure as every year?
  21. § 2 Zur Konzeption des Handbuchs
  22. Performing (the) digital
  23. Open access to science on ecosystem services and biodiversity
  24. Including software aspects in green IT
  25. Circularity in green chemical products, processes and services
  26. Innovation in Sustainable Supply Chains
  27. Eine Frage von Genauigkeit?
  28. Gefährder
  29. Partizipatives Regieren in der EU
  30. Wasser und nachhaltige Chemie
  31. "Konfrontative Pädagogik"
  32. Informationspotentiale
  33. Supplementing Q-method with narratives
  34. Üben, Üben!
  35. The Principles of Public International Law and their Influence on Space Contracts